Atlas Trials

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Clinical trial NCT01485887 · COMPLETED

Trial details

NCT number
NCT01485887
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2012-01-01
Primary completion
2014-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.